REVOLAB
LIVE

Serial Number

98246466

Owner

Revotech Single Member P.C.

Attorney

Sarah Anne Keefe

Filing Date

Oct 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

REVOLAB Trademark

Serial Number: 98246466

REVOLAB is a trademark filed by Revotech Single Member P.C. on October 30, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Revotech Single Member P.C. (3 trademarks)

138 Tritonos str.
Athens 17562 , GR

Entity Type: 99

Trademark Details

Filing Date

October 30, 2023

Registration Date

Not Registered

Goods & Services

Medical services for the diagnosis of diseases of the human body; medical examination of persons; medical tele-reporting being medical services; medical imaging services; medical analysis services in connection with the treatment of persons provided by a medical laboratory; medical analysis services for diagnostic and therapeutic purposes provided by medical laboratories; medical testing services in connection with the diagnosis and treatment of diseases; provision of reports in connection with medical examinations of persons

Downloadable computer operating programs used in the health care and medical field; downloadable computer application software for data processing and hardware, in the field of diagnostic and health care services; downloadable computer software for facilitating electronic commerce relating to diagnostic and health care services in the nature of providing consulting services; downloadable machine learning software for health care consulting; computer hardware for health care consulting services

Scientific research for medical purposes; provision of information in relation to scientific research in the field of biochemistry; scientific laboratory services; research and development services in the field of cytology and nosology; none of the aforementioned services in the pharmaceutical field and/or for the development of medicines

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 9, 2026 GNFN
FINAL REFUSAL E-MAILED
Jun 9, 2026 GNFR
FINAL REFUSAL WRITTEN
Jun 9, 2026 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 22, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 9, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 22, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 21, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 21, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jan 21, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 12, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 14, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 14, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 12, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 12, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 12, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 11, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2023 NWOS
NEW APPLICATION ENTERED
Nov 2, 2023 NWAP